The Australasian Society of Clinical Immunology and Allergy (ASCIA) have released a position statement on COVID-19 vaccination. The statement reflects the COVID-19 vaccines the Therapeutic Goods Administration (TGA) has granted provisional approval for use in Australia, as well as vaccines that may also be granted provisional approval in the future. It contains guidance based on current data for COVID-19 vaccination in people with allergic conditions, immunodeficiencies and autoimmune conditions, pregnant and breastfeeding women and children under 16 years of age.
You can access the full statement via the link below:
ASCIA: Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination Position Statement